Paragon 28 Inc
General ticker "FNA" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $850.0M
Paragon 28 Inc does not follow the US Stock Market performance with the rate: -19.0%.
Estimated limits based on current volatility of 3.2%: low 9.67$, high 10.32$
Factors to consider:
- US accounted for 87.2% of revenue in the fiscal year ended 2022-12-31
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [6.54$, 14.33$]
- 2024-12-30 to 2025-12-30 estimated range: [6.06$, 13.14$]
Financial Metrics affecting the FNA estimates:
- Negative: Non-GAAP EPS, $ of -0.53 <= 0.10
- Negative: Operating profit margin, % of -14.71 <= 1.03
- Negative: Operating cash flow per share per price, % of -6.29 <= 2.35
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
- Positive: -0.96 < Investing cash flow per share, $ of -0.33
Short-term FNA quotes
Long-term FNA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $147.46MM | $181.38MM | $216.39MM |
| Operating Expenses | $158.24MM | $243.43MM | $253.70MM |
| Operating Income | $-10.78MM | $-62.05MM | $-37.31MM |
| Non-Operating Income | $-2.21MM | $-5.34MM | $-10.32MM |
| Interest Expense | $1.72MM | $4.13MM | $5.17MM |
| R&D Expense | $16.13MM | $24.65MM | $30.08MM |
| Income(Loss) | $-12.98MM | $-67.39MM | $-47.63MM |
| Taxes | $0.71MM | $-0.06MM | $0.21MM |
| Profit(Loss) | $-13.69MM | $-67.33MM | $-47.84MM |
| Stockholders Equity | $192.19MM | $140.93MM | $177.74MM |
| Inventory | $40.24MM | $60.95MM | $98.06MM |
| Assets | $234.54MM | $254.11MM | $340.70MM |
| Operating Cash Flow | $-3.32MM | $-49.18MM | $-63.89MM |
| Capital expenditure | $21.29MM | $43.09MM | $28.03MM |
| Investing Cash Flow | $-35.49MM | $-60.69MM | $-26.99MM |
| Financing Cash Flow | $131.10MM | $39.49MM | $128.65MM |
| Earnings Per Share* | $-0.18 | $-0.88 | $-0.58 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.